How many patents does
Salk Institute For Biological Studies have?
patents
697
families
132
granted
106
applications
591
US
209
WO
145
EP
113
CN
34
JP
31
KR
18
RoW
147
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Salk Institute For Biological Studies
Top ten assignees appearing on patents
2009 - 2018
| mitobridge | 15 |
| neurovigil | 11 |
| sanofi | 8 |
| xetrios therapeutics | 5 |
| labrys biologics | 3 |
| celldex therapeutics | 2 |
| metacrine | 1 |
| mitokyne | 1 |
| center of regenerative medicine | 1 |
| teva pharmaceuticals international | 1 |
2009
2018
| mitobridge | 2 |
| metacrine | 1 |
| sanofi | 1 |
Salk Institute For Biological Studies
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| receptor(sstr2)-selective somatostatin antagonists | 23 | 2006 |
| methods for treating metabolic disorders using fgf | 22 | 2010 |
| adenoviral assembly method | 21 | 2010 |
| anti-cancer adenoviruses | 18 | 2010 |
| somatostatin receptor 2 antagonists | 15 | 2006 |
| chimeric fibroblast growth factor 21 proteins and methods of use | 15 | 2012 |
| adenoviral tumor diagnostics | 15 | 2012 |
| camkii, ip3r, calcineurin, p38 and mk2/3 inhibitors to treat metabolic disturbances of o… 🛈 | 14 | 2011 |
| use of vitamin d receptor agonists and precursors to treat fibrosis | 14 | 2007 |
| methods of identifying sleep and waking patterns and uses | 14 | 2008 |